On 27th of September 2012 the results of 2nd edition of INNOTECH programme was announced. F1 Pharma was on the list of the beneficiaries.
INNOTECH is a programme which aims to help research entities and businesses to carry out innovative projects representing various scientific areas and industrial sectors. The programme is being organised by the National Centre of Research and Development.
F1 Pharma received the funding in collaboration with the Pharmaceutical Institute of Warsaw and the Jagiellonian Centre of Innovation.
The project „Synthesis and new technology of production of drug containing 5-a reductase inhibitor” will be carried out between 2013 and 2015. The total value of the project is 5 892 550 PLN.